Efferent Labs is a preclinical stage medical technology company focused on implantable biosensors. Our CytoComm™ Biosensor Platform is designed to serve as a real-time monitoring system, using living cells to assess cellular function in vivo. Our system is built to transmit live data through the cloud to our data acquisition and analysis software, providing real-time information to researchers and clinicians.

The CytoComm™ Biosensor Platform has multiple applications including preclinical R&D, clinical testing, oncology, cardiology, and metabolic diseases.

“Living cells can tell us more about life processes than any instrument can.”



Real-time feedback of cellular function


Living cell lines provide a powerful tool to assess cellular function in vivo.



More data, more often

CytoComm™ is being designed as a platform that wirelessly gathers targeted real-time data for analysis by researchers and physicians.





Efferent Labs Taps Evotec to Advance Implantable Biosensor for R&D, Oncology

FierceBiotech Efferent Labs has inked a deal with Evotec to develop its implantable biosensor technology. The device, which is injected...

Read more

Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product

January 9, 2017 FOR MORE INFORMATION CONTACT:  press@efferentlabs.com Download the Press Release

Read more